The hepatitis C drug development pipeline.
Raymond
Daniel
D
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D015195:Drug Design; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents